HIFU was.....: Little Rock Support Group (Man 2 Man)

[Guest guest]

The so called “Stuttgart definition”

only applies to HIFU and if this is the study that established the definition

it seems a little arrogant to set up a definition of failure and then say that

a treatment doesn’t meet that definition??

All the best

Prostate men need enlightening, not

frightening

Terry Herbert - diagnosed in 1996 and

still going strong

Read A Strange Place for unbiased information at http://www.yananow.org/StrangePlace/index.html

From: ProstateCancerSupport [mailto:ProstateCancerSupport ] On Behalf Of Chuck Maack

Sent: Thursday, 3 February 2011

4:28 AM

To: ProstateCancerSupport

Subject: RE:

Re: Little Rock Support Group (Man 2 Man)

For all,

If considering

traveling outside the U.S. and paying out-of-pocket the expense of High

Intensity Focused Ultrasonogaphy (HIFU), please note the following remark from

this six-year study:

http://tinyurl.com/26ss6tk

“In

our experience, Ablatherm treatment for clinically localized prostate

cancer was associated with a high rate of biochemical failure as determined by

the 'Stuttgart'

definition, and did not achieve effective cancer control. The PSA nadir value

after HIFU treatment was a significant predictor of treatment failure.”

The “Stuttgart”

definition is a new, more accurate, definition of biochemical failure.

See:

http://www.ncbi.nlm.nih.gov/pubmed/19388986

And here is more:

From The

“New” Prostate Cancer InfoLink (http://tinyurl.com/3x5y4st):

Canadian practice guideline does NOT recommend HIFU

High-intensity focused ultrasound (HIFU) is legally available in Canada as a

method for the treatment of prostate cancer. However, a new Canadian practice

guideline states that, “HIFU cannot currently be recommended as an

alternative to accepted curative treatment approaches for localized prostate

cancer.”

The new guidance document has been issued

by the Genitourinary Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based

Care, and the full text of the guideline is available on line.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910764/pdf/cuaj-4-232.pdf

Chuck